Prognostic value of the combination of epidermal growth factor receptor and c-erbB-2 in breast cancer
- 1 February 2003
- Vol. 133 (2) , 219-221
- https://doi.org/10.1067/msy.2003.32
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Prognostic value of c‐erbB2 expression in breast cancerJournal of Surgical Oncology, 2002
- Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancerBreast Cancer Research and Treatment, 2002
- EGFR family expression in breast carcinomas. c‐erbB‐2 and c‐erbB‐4 receptors have different effects on survivalThe Journal of Pathology, 2001
- Molecular mechanisms underlying ErbB2/HER2 action in breast cancerOncogene, 2000
- Prognostic significance of c-erbB-2/neu amplification and epidermal growth factor receptor (EGFR) in primary breast cancer and theor relation to estradiol receptor (ER) statusClinica Chimica Acta; International Journal of Clinical Chemistry, 1997
- Prognostic significance of co-expression of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer patientsThe American Journal of Surgery, 1992